pubmed-article:12927428 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12927428 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:12927428 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:12927428 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:12927428 | lifeskim:mentions | umls-concept:C1861172 | lld:lifeskim |
pubmed-article:12927428 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:12927428 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
pubmed-article:12927428 | lifeskim:mentions | umls-concept:C0694643 | lld:lifeskim |
pubmed-article:12927428 | pubmed:issue | 9382 | lld:pubmed |
pubmed-article:12927428 | pubmed:dateCreated | 2003-8-20 | lld:pubmed |
pubmed-article:12927428 | pubmed:abstractText | Oral oestrogen-replacement therapy (ERT) activates blood coagulation and increases the risk of venous thromboembolism (VTE) in postmenopausal women. Transdermal ERT has little effect on haemostasis, but data assessing its effect on thrombotic process are scarce. We aimed to examine the effect of the route of oestrogen administration on VTE risk. | lld:pubmed |
pubmed-article:12927428 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12927428 | pubmed:language | eng | lld:pubmed |
pubmed-article:12927428 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12927428 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12927428 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12927428 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12927428 | pubmed:month | Aug | lld:pubmed |
pubmed-article:12927428 | pubmed:issn | 1474-547X | lld:pubmed |
pubmed-article:12927428 | pubmed:author | pubmed-author:OgerEmmanuelE | lld:pubmed |
pubmed-article:12927428 | pubmed:author | pubmed-author:ScarabinPierr... | lld:pubmed |
pubmed-article:12927428 | pubmed:author | pubmed-author:Plu-BureauGen... | lld:pubmed |
pubmed-article:12927428 | pubmed:author | pubmed-author:EStrogen... | lld:pubmed |
pubmed-article:12927428 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:12927428 | pubmed:day | 9 | lld:pubmed |
pubmed-article:12927428 | pubmed:volume | 362 | lld:pubmed |
pubmed-article:12927428 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12927428 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12927428 | pubmed:pagination | 428-32 | lld:pubmed |
pubmed-article:12927428 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:meshHeading | pubmed-meshheading:12927428... | lld:pubmed |
pubmed-article:12927428 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12927428 | pubmed:articleTitle | Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. | lld:pubmed |
pubmed-article:12927428 | pubmed:affiliation | INSERM Cardiovascular Epidemiology Unit U258, Villejuif, France. scarabin@vjf.inserm.fr <scarabin@vjf.inserm.fr> | lld:pubmed |
pubmed-article:12927428 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12927428 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:12927428 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:12927428 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12927428 | lld:pubmed |